1Tuomi T, Groop LC, Zimmet PZ,et al. Antibodies to gJutmic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin dependent onset of disease. Diabetes, 1993, 42:359-362.
2Landin-Olsson M. Latent autoimmune diabetes in adults. 2002, Ann N Y Acad Sci, 2002, 958:112-116.
3Falomi A, Calcinam F. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults. Ann N Y Acad Sci,2002,958:99-106.
4Turner R, Stratton I, Horton V,et al.UKPDS 2.5:autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes.UK Prospective Diabetes Study Group. Lancet, 1997, 350(9087):1288-1293.
5Reinsch B, Zimmy S, Schatz H, et 81. Glutamic acid decarboxylase and tyresine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients.Med Klin (Munich),2003,98(2):67-71.
6Kanungo A,Sanjeevi CB. IA-2 autoantihodies are predominant in latent autoimmune diabetes in adults patients from eastern India.Ann N Y Acad Sci, 2003,1005:390-394.
7Kawasaki E, Abiru N, Ide A. Epitope analysis of GAD65 autoantibodies in Japanese patients with autoimmune diabetes. Ann N Y Acad Sci, 2003,1005:440-448.
8Falomi A, Gambelunghe G, Forini F,et al. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in aduh-onset diabetes mellitus. J Clin Endoerinol Metab,2000,85(1):309-316.
9Gambelunghe G, Ghaderi M, Tortoioli C, et al.Two distinct MICA gene markers discriminate major autoimmune diabetes types.J Clin Endoerinol Metab, 2001, 86(8):3754-3760.
10Monetini L, Cavallo MG, Manfrini S, et al. Antibodies to bovine betacasein in diabetes and other autoimmune diseases. Horm Metab Res,2002, 34:455-459.
